{"id":"https://openalex.org/W2991234928","doi":"https://doi.org/10.24875/gmm.19005494","title":"Experiencia con el uso de olaparib en pacientes con c\u00e1ncer de ovario","display_name":"Experiencia con el uso de olaparib en pacientes con c\u00e1ncer de ovario","alternate_titles":[],"publication_year":2019,"publication_date":"2019-11-12","ids":{"openalex":"https://openalex.org/W2991234928","doi":"https://doi.org/10.24875/gmm.19005494","mag":"2991234928","pmid":"https://pubmed.ncbi.nlm.nih.gov/31787769"},"language":"es","primary_location":{"id":"doi:10.24875/gmm.19005494","doi":"https://doi.org/10.24875/gmm.19005494","is_oa":true,"landing_page_url":"https://doi.org/10.24875/gmm.19005494","pdf_url":"https://gacetamedicademexico.com/files/gmm_19_155_6_585-589.pdf","source":{"id":"https://openalex.org/S55067821","display_name":"Gaceta M\u00e9dica de M\u00e9xico","issn_l":"0016-3813","issn":["0016-3813","2696-1288"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","dongbi-c","jufo-1","medline","norway-1","oarl","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310319614","host_organization_name":"Academia Nacional de Medicina de M\u00e9xico","host_organization_lineage":["https://openalex.org/P4310319614"],"host_organization_lineage_names":["Academia Nacional de Medicina de M\u00e9xico"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gaceta M\u00e9dica de M\u00e9xico","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2991234928"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://gacetamedicademexico.com/files/gmm_19_155_6_585-589.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006305444","display_name":"Dolores Gallardo\u2010Rinc\u00f3n","orcid":"https://orcid.org/0000-0002-0628-8290","observed_orcids":["https://orcid.org/0000-0002-0628-8290"]},"institutions":[{"id":"https://openalex.org/I4210153971","display_name":"Instituto Nacional de Cancerolog\u00eda","ror":"https://ror.org/04z3afh10","country_code":"MX","type":"government","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210153971"]}],"countries":["MX"],"is_corresponding":true,"raw_author_name":"Dolores Gallardo-Rinc\u00f3n","raw_affiliation_strings":["Departamento de Oncolog\u00eda M\u00e9dica. Instituto Nacional de Cancerolog\u00eda. Ciudad de M\u00e9xico, M\u00e9xico","Departamento de Oncolog\u00eda M\u00e9dica;","Programa de C\u00e1ncer de Ovario;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departamento de Oncolog\u00eda M\u00e9dica. Instituto Nacional de Cancerolog\u00eda. Ciudad de M\u00e9xico, M\u00e9xico","institution_ids":["https://openalex.org/I4210153971"]},{"raw_affiliation_string":"Departamento de Oncolog\u00eda M\u00e9dica;","institution_ids":[]},{"raw_affiliation_string":"Programa de C\u00e1ncer de Ovario;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077899943","display_name":"Gabriela Alamilla-Garc\u00eda","orcid":"https://orcid.org/0000-0002-6957-2336","observed_orcids":["https://orcid.org/0000-0002-6957-2336"]},"institutions":[{"id":"https://openalex.org/I4210153971","display_name":"Instituto Nacional de Cancerolog\u00eda","ror":"https://ror.org/04z3afh10","country_code":"MX","type":"government","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210153971"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Gabriela Alamilla-Garc\u00eda","raw_affiliation_strings":["Departamento de Oncolog\u00eda M\u00e9dica. Instituto Nacional de Cancerolog\u00eda. Ciudad de M\u00e9xico, M\u00e9xico","Departamento de Oncolog\u00eda M\u00e9dica;","Programa de C\u00e1ncer de Ovario;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departamento de Oncolog\u00eda M\u00e9dica. Instituto Nacional de Cancerolog\u00eda. Ciudad de M\u00e9xico, M\u00e9xico","institution_ids":["https://openalex.org/I4210153971"]},{"raw_affiliation_string":"Departamento de Oncolog\u00eda M\u00e9dica;","institution_ids":[]},{"raw_affiliation_string":"Programa de C\u00e1ncer de Ovario;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050112856","display_name":"Edgar Montes-Serv\u00edn","orcid":"https://orcid.org/0000-0003-3746-6739","observed_orcids":["https://orcid.org/0000-0003-3746-6739"]},"institutions":[{"id":"https://openalex.org/I4210153971","display_name":"Instituto Nacional de Cancerolog\u00eda","ror":"https://ror.org/04z3afh10","country_code":"MX","type":"government","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210153971"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Edgar Montes-Serv\u00edn","raw_affiliation_strings":["Programa de C\u00e1ncer de Ovario. Instituto Nacional de Cancerolog\u00eda. Ciudad de M\u00e9xico, M\u00e9xico","Programa de C\u00e1ncer de Ovario;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Programa de C\u00e1ncer de Ovario. Instituto Nacional de Cancerolog\u00eda. Ciudad de M\u00e9xico, M\u00e9xico","institution_ids":["https://openalex.org/I4210153971"]},{"raw_affiliation_string":"Programa de C\u00e1ncer de Ovario;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070155590","display_name":"Flavia Morales-V\u00e1zquez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153971","display_name":"Instituto Nacional de Cancerolog\u00eda","ror":"https://ror.org/04z3afh10","country_code":"MX","type":"government","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210153971"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Flavia Morales-V\u00e1zquez","raw_affiliation_strings":["Departamento de Oncolog\u00eda M\u00e9dica. Instituto Nacional de Cancerolog\u00eda. Ciudad de M\u00e9xico, M\u00e9xico","Departamento de Oncolog\u00eda M\u00e9dica;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departamento de Oncolog\u00eda M\u00e9dica. Instituto Nacional de Cancerolog\u00eda. Ciudad de M\u00e9xico, M\u00e9xico","institution_ids":["https://openalex.org/I4210153971"]},{"raw_affiliation_string":"Departamento de Oncolog\u00eda M\u00e9dica;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063591199","display_name":"Claudia Cano-Blanco","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153971","display_name":"Instituto Nacional de Cancerolog\u00eda","ror":"https://ror.org/04z3afh10","country_code":"MX","type":"government","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210153971"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Claudia Cano-Blanco","raw_affiliation_strings":["Departamento de Oncolog\u00eda M\u00e9dica. Instituto Nacional de Cancerolog\u00eda. Ciudad de M\u00e9xico, M\u00e9xico","Departamento de Oncolog\u00eda M\u00e9dica;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departamento de Oncolog\u00eda M\u00e9dica. Instituto Nacional de Cancerolog\u00eda. Ciudad de M\u00e9xico, M\u00e9xico","institution_ids":["https://openalex.org/I4210153971"]},{"raw_affiliation_string":"Departamento de Oncolog\u00eda M\u00e9dica;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074572857","display_name":"Jaime Alberto Coronel-Mart\u00ednez","orcid":"https://orcid.org/0000-0003-2874-8996","observed_orcids":["https://orcid.org/0000-0003-2874-8996"]},"institutions":[{"id":"https://openalex.org/I4210153971","display_name":"Instituto Nacional de Cancerolog\u00eda","ror":"https://ror.org/04z3afh10","country_code":"MX","type":"government","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210153971"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Jaime Coronel-Mart\u00ednez","raw_affiliation_strings":["Departamento de Oncolog\u00eda M\u00e9dica. Instituto Nacional de Cancerolog\u00eda. Ciudad de M\u00e9xico, M\u00e9xico","Departamento de Oncolog\u00eda M\u00e9dica;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departamento de Oncolog\u00eda M\u00e9dica. Instituto Nacional de Cancerolog\u00eda. Ciudad de M\u00e9xico, M\u00e9xico","institution_ids":["https://openalex.org/I4210153971"]},{"raw_affiliation_string":"Departamento de Oncolog\u00eda M\u00e9dica;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081650684","display_name":"Antonio Bahena-Gonz\u00e1lez","orcid":"https://orcid.org/0000-0003-3199-7926","observed_orcids":["https://orcid.org/0000-0003-3199-7926"]},"institutions":[{"id":"https://openalex.org/I4210153971","display_name":"Instituto Nacional de Cancerolog\u00eda","ror":"https://ror.org/04z3afh10","country_code":"MX","type":"government","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210153971"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Antonio Bahena-Gonz\u00e1lez","raw_affiliation_strings":["Departamento de Oncolog\u00eda M\u00e9dica. Instituto Nacional de Cancerolog\u00eda. Ciudad de M\u00e9xico, M\u00e9xico","Departamento de Oncolog\u00eda M\u00e9dica;","Programa de C\u00e1ncer de Ovario;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departamento de Oncolog\u00eda M\u00e9dica. Instituto Nacional de Cancerolog\u00eda. Ciudad de M\u00e9xico, M\u00e9xico","institution_ids":["https://openalex.org/I4210153971"]},{"raw_affiliation_string":"Departamento de Oncolog\u00eda M\u00e9dica;","institution_ids":[]},{"raw_affiliation_string":"Programa de C\u00e1ncer de Ovario;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103344626","display_name":"Raquel Gerson-Cwilich","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134034","display_name":"Centro M\u00e9dico ABC","ror":"https://ror.org/03e36d037","country_code":"MX","type":"healthcare","lineage":["https://openalex.org/I4210134034"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Raquel Gerson-Cwilich","raw_affiliation_strings":["Departamento de Oncolog\u00eda M\u00e9dica, Centro de C\u00e1ncer, Centro M\u00e9dico ABC. Ciudad de M\u00e9xico, M\u00e9xico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departamento de Oncolog\u00eda M\u00e9dica, Centro de C\u00e1ncer, Centro M\u00e9dico ABC. Ciudad de M\u00e9xico, M\u00e9xico","institution_ids":["https://openalex.org/I4210134034"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077288132","display_name":"David Isla\u2010Ortiz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119015","display_name":"Instituto Nacional de Cancerolog\u00eda","ror":"https://ror.org/02hdnbe80","country_code":"CO","type":"healthcare","lineage":["https://openalex.org/I4210119015"]},{"id":"https://openalex.org/I4210153971","display_name":"Instituto Nacional de Cancerolog\u00eda","ror":"https://ror.org/04z3afh10","country_code":"MX","type":"government","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210153971"]}],"countries":["CO","MX"],"is_corresponding":false,"raw_author_name":"David Isla-Ortiz","raw_affiliation_strings":["Departamento de Ginecolog\u00eda Oncol\u00f3gica. Instituto Nacional de Cancerolog\u00eda. Ciudad de M\u00e9xico, M\u00e9xico","Departamento de Ginecolog\u00eda Oncol\u00f3gica. Instituto Nacional de Cancerolog\u00eda;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departamento de Ginecolog\u00eda Oncol\u00f3gica. Instituto Nacional de Cancerolog\u00eda. Ciudad de M\u00e9xico, M\u00e9xico","institution_ids":["https://openalex.org/I4210153971"]},{"raw_affiliation_string":"Departamento de Ginecolog\u00eda Oncol\u00f3gica. Instituto Nacional de Cancerolog\u00eda;","institution_ids":["https://openalex.org/I4210119015","https://openalex.org/I4210153971"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050202499","display_name":"Alfredo Toledo\u2010Leyva","orcid":"https://orcid.org/0000-0003-2537-8790","observed_orcids":["https://orcid.org/0000-0003-2537-8790"]},"institutions":[{"id":"https://openalex.org/I4210153971","display_name":"Instituto Nacional de Cancerolog\u00eda","ror":"https://ror.org/04z3afh10","country_code":"MX","type":"government","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210153971"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Alfredo Toledo-Leyva","raw_affiliation_strings":["Programa de C\u00e1ncer de Ovario. Instituto Nacional de Cancerolog\u00eda. Ciudad de M\u00e9xico, M\u00e9xico","Programa de C\u00e1ncer de Ovario;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Programa de C\u00e1ncer de Ovario. Instituto Nacional de Cancerolog\u00eda. Ciudad de M\u00e9xico, M\u00e9xico","institution_ids":["https://openalex.org/I4210153971"]},{"raw_affiliation_string":"Programa de C\u00e1ncer de Ovario;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103021519","display_name":"Elizabeth Montes-Serv\u00edn","orcid":"https://orcid.org/0000-0002-9359-7904","observed_orcids":["https://orcid.org/0000-0002-9359-7904"]},"institutions":[{"id":"https://openalex.org/I4210153971","display_name":"Instituto Nacional de Cancerolog\u00eda","ror":"https://ror.org/04z3afh10","country_code":"MX","type":"government","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210153971"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Elizabeth Montes-Serv\u00edn","raw_affiliation_strings":["Programa de C\u00e1ncer de Ovario. Instituto Nacional de Cancerolog\u00eda. Ciudad de M\u00e9xico, M\u00e9xico","Programa de C\u00e1ncer de Ovario;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Programa de C\u00e1ncer de Ovario. Instituto Nacional de Cancerolog\u00eda. Ciudad de M\u00e9xico, M\u00e9xico","institution_ids":["https://openalex.org/I4210153971"]},{"raw_affiliation_string":"Programa de C\u00e1ncer de Ovario;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047697691","display_name":"David Michel-Tello","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153971","display_name":"Instituto Nacional de Cancerolog\u00eda","ror":"https://ror.org/04z3afh10","country_code":"MX","type":"government","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210153971"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"David Michel-Tello","raw_affiliation_strings":["Programa de C\u00e1ncer de Ovario. Instituto Nacional de Cancerolog\u00eda. Ciudad de M\u00e9xico, M\u00e9xico","Programa de C\u00e1ncer de Ovario;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Programa de C\u00e1ncer de Ovario. Instituto Nacional de Cancerolog\u00eda. Ciudad de M\u00e9xico, M\u00e9xico","institution_ids":["https://openalex.org/I4210153971"]},{"raw_affiliation_string":"Programa de C\u00e1ncer de Ovario;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012798860","display_name":"Raquel Espinosa-Romero","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153971","display_name":"Instituto Nacional de Cancerolog\u00eda","ror":"https://ror.org/04z3afh10","country_code":"MX","type":"government","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210153971"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Raquel Espinosa-Romero","raw_affiliation_strings":["Departamento de Oncolog\u00eda M\u00e9dica. Instituto Nacional de Cancerolog\u00eda. Ciudad de M\u00e9xico, M\u00e9xico","Departamento de Oncolog\u00eda M\u00e9dica;","Programa de C\u00e1ncer de Ovario;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departamento de Oncolog\u00eda M\u00e9dica. Instituto Nacional de Cancerolog\u00eda. Ciudad de M\u00e9xico, M\u00e9xico","institution_ids":["https://openalex.org/I4210153971"]},{"raw_affiliation_string":"Departamento de Oncolog\u00eda M\u00e9dica;","institution_ids":[]},{"raw_affiliation_string":"Programa de C\u00e1ncer de Ovario;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5006305444"],"corresponding_institution_ids":["https://openalex.org/I4210153971"],"apc_list":null,"apc_paid":null,"fwci":0.2169,"has_fulltext":true,"cited_by_count":3,"citation_normalized_percentile":{"value":0.52834867,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"155","issue":"6","first_page":"585","last_page":"589"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/olaparib","display_name":"olaparib","score":1.0},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.9269999861717224},{"id":"https://openalex.org/keywords/brca1-mutation","display_name":"BRCA1 mutation","score":0.9350000023841858},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.9860000014305115},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.8970000147819519},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9980000257492065},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.6690000295639038},{"id":"https://openalex.org/keywords/hereditary-ovarian-cancer","display_name":"hereditary ovarian cancer","score":0.7400000095367432}],"concepts":[{"id":"https://openalex.org/C2779962180","wikidata":"https://www.wikidata.org/wiki/Q7083106","display_name":"Olaparib","level":5,"score":0.9915944337844849},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7576935291290283},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.585807740688324},{"id":"https://openalex.org/C2780194787","wikidata":"https://www.wikidata.org/wiki/Q4836333","display_name":"BRCA mutation","level":4,"score":0.5385708808898926},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.5329991579055786},{"id":"https://openalex.org/C2779138821","wikidata":"https://www.wikidata.org/wiki/Q7118227","display_name":"PARP inhibitor","level":5,"score":0.5098142027854919},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4451611042022705},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4013374149799347},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3846834599971771},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.36629176139831543},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.3650786280632019},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.23241153359413147},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1799045205116272},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1772979497909546},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1520838439464569},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000067856","descriptor_name":"Poly(ADP-ribose) Polymerase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000067856","descriptor_name":"Poly(ADP-ribose) Polymerase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000077982","descriptor_name":"Progression-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008800","descriptor_name":"Mexico","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D010793","descriptor_name":"Phthalazines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D010793","descriptor_name":"Phthalazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019313","descriptor_name":"BRCA1 Protein","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.24875/gmm.19005494","doi":"https://doi.org/10.24875/gmm.19005494","is_oa":true,"landing_page_url":"https://doi.org/10.24875/gmm.19005494","pdf_url":"https://gacetamedicademexico.com/files/gmm_19_155_6_585-589.pdf","source":{"id":"https://openalex.org/S55067821","display_name":"Gaceta M\u00e9dica de M\u00e9xico","issn_l":"0016-3813","issn":["0016-3813","2696-1288"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","dongbi-c","jufo-1","medline","norway-1","oarl","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310319614","host_organization_name":"Academia Nacional de Medicina de M\u00e9xico","host_organization_lineage":["https://openalex.org/P4310319614"],"host_organization_lineage_names":["Academia Nacional de Medicina de M\u00e9xico"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gaceta M\u00e9dica de M\u00e9xico","raw_type":"journal-article"},{"id":"pmid:31787769","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31787769","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gaceta medica de Mexico","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.24875/gmm.19005494","doi":"https://doi.org/10.24875/gmm.19005494","is_oa":true,"landing_page_url":"https://doi.org/10.24875/gmm.19005494","pdf_url":"https://gacetamedicademexico.com/files/gmm_19_155_6_585-589.pdf","source":{"id":"https://openalex.org/S55067821","display_name":"Gaceta M\u00e9dica de M\u00e9xico","issn_l":"0016-3813","issn":["0016-3813","2696-1288"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","dongbi-c","jufo-1","medline","norway-1","oarl","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310319614","host_organization_name":"Academia Nacional de Medicina de M\u00e9xico","host_organization_lineage":["https://openalex.org/P4310319614"],"host_organization_lineage_names":["Academia Nacional de Medicina de M\u00e9xico"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gaceta M\u00e9dica de M\u00e9xico","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2991234928.pdf","grobid_xml":"https://content.openalex.org/works/W2991234928.grobid-xml"},"referenced_works_count":8,"referenced_works":["https://openalex.org/W1514438602","https://openalex.org/W1567221268","https://openalex.org/W1836674146","https://openalex.org/W1969458729","https://openalex.org/W2130078242","https://openalex.org/W2589712516","https://openalex.org/W2737389832","https://openalex.org/W2897430921"],"related_works":["https://openalex.org/W4281702465","https://openalex.org/W3025893978","https://openalex.org/W2947176521","https://openalex.org/W2398878382","https://openalex.org/W7127308080","https://openalex.org/W3019010909","https://openalex.org/W4400272644","https://openalex.org/W4407275693","https://openalex.org/W4283211481","https://openalex.org/W2562267900"],"abstract_inverted_index":{"INTRODUCTION:":[0],"More":[1],"than":[2],"the":[3,22,26,50,54,111,151],"twenty":[4],"percent":[5],"of":[6,18,56,105,110,117],"ovarian":[7],"cancers":[8],"are":[9,38],"hereditary,":[10],"and":[11,80,88,127,135,142,177],"most":[12],"have":[13,25,184],"BRCA":[14],"mutations.":[15],"The":[16,115],"30%":[17],"Mexican":[19],"patients":[20,68,94,123],"with":[21,70,97,139,150,181],"BRCA1":[23,27,98],"mutation":[24,33,99,153,183],"gene":[28],"exon":[29],"9-12del":[30],"deletion":[31],"founder":[32,113,152,182],"(BRCA1":[34],"ex9-12del).":[35],"BRCA-mutated":[36],"tumors":[37],"more":[39],"sensitive":[40],"to":[41,75],"PARP":[42],"inhibitors":[43],"such":[44],"as":[45,171],"olaparib.":[46],"OBJECTIVE:":[47],"To":[48],"show":[49],"clinical":[51,83],"experience":[52],"on":[53,125],"use":[55],"olaparib":[57,71],"at":[58],"Instituto":[59],"Nacional":[60],"de":[61],"Cancerolog\u00eda":[62],"in":[63,102,162],"Mexico.":[64],"METHOD:":[65],"Ovarian":[66],"cancer":[67],"treated":[69,124,138],"from":[72],"November":[73],"2016":[74],"December":[76],"2018":[77],"were":[78,90,95,108,158],"studied,":[79],"their":[81],"characteristics,":[82],"response,":[84],"progression-free":[85],"survival":[86],"(PFS)":[87],"toxicities":[89],"described.":[91],"RESULTS:":[92],"Nineteen":[93],"assessed,":[96],"being":[100],"found":[101],"78.9%,":[103],"out":[104],"which":[106],"21.1%":[107],"carriers":[109],"ex9-12del":[112],"mutation.":[114],"median":[116],"PFS":[118,169],"was":[119,131,146],"12":[120],"months;":[121],"for":[122,136],"second":[126,178],"third":[128],"line":[129,144],"it":[130,145],">":[132],"15":[133],"months,":[134],"those":[137,160],"a":[140,175],"fourth":[141],"subsequent":[143],"8.3":[147],"months.":[148],"Patients":[149,180],"had":[154,185],"better":[155],"results.":[156],"Toxicities":[157],"like":[159],"reported":[161],"previous":[163],"studies.":[164],"CONCLUSIONS:":[165],"Olaparib":[166],"offers":[167],"greater":[168],"benefit":[170],"maintenance":[172],"therapy":[173],"after":[174],"first":[176],"relapse.":[179],"sustained":[186],"PFS.":[187]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2991234928","counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2019-12-05T00:00:00"}
